Clinical Trials in Baltimore

Showing 3901-3920 of 23,476 trials

Hybrid Robot+FES Stroke Rehabilitation

NCT04550728

The investigators have developed a novel robot-guided stretching under intelligent control and combine it with active movement training, which helped increase joint ROM, reduce spasticity and joint stiffness, increase muscle force output, and improve locomotion. However, for stroke survivors with sensorimotor impairment, their peripheral muscle may not sufficiently be recruited. Functional electrical stimulation (FES), has been shown its advantage to activate the peripheral muscles for people with neurological conditions. The investigators thus make a hybrid robot-FES rehabilitation system, combining the advantage of robot and FES technologies for stroke motor recovery. The investigators further would like to translate the technologies from lab to home-based training. Thus, the investigators will conduct a randomized, controlled, primarily home-based clinical trial using an ankle robot alone or combined with functional electrical stimulation (FES) to treat sensorimotor and locomotion impairments post-stroke.

Stroke

University of Maryland, Baltimore60 participantsStarted Aug 2021

Baltimore, Maryland, United States

TERMINATEDPhase 1< 1 mile

A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

NCT05336409

ELiPSE-1 is a Phase 1, multi-center, dose-finding study to evaluate the safety, pharmacokinetics, and preliminary efficacy of CNTY-101 in participants with relapsed or refractory cluster of differentiation (CD)19-positive B-cell malignancies.

R/R CD19-Positive B-Cell MalignanciesIndolent Non-Hodgkin LymphomaAggressive Non-Hodgkin Lymphoma

Century Therapeutics, Inc.28 participantsStarted Jan 2023

Gilbert, Arizona, United States • Los Angeles, California, United States • San Diego, California, United States +13 more locations

Hybrid Robot+FES Stroke Rehabilitation

A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

Find Trials by Condition in Baltimore

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

The Johns Hopkins Heartburn Center Registry

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

Study of Aspirin in Patients With Vestibular Schwannoma

Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)